BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program USA - English USA - English Deutschland - Deutsch
Pan-Sarbecovirus Vaccines Identified by WHO as a Critical Need
VANCOUVER, BC
,
June 3, 2022
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that The
Ohio State...
Zur Pressemeldung auf www.prnewswire.com